Showing results (571-580 of 848) with videos related to
Sort By:
Pageof 85
Drug Metabolism Reviews|July 16, 2009
Therapeutic management of allergic diseasesJean-Baptiste Watelet, Michel Gillard, Margherita Strolin Benedetti, et al.Drug Metabolism Reviews|July 16, 2009
Physiologically based pharmacokinetics (PBPK)Pascal Espié, Dominique Tytgat, Maria-Laura Sargentini-Maier, et al.Drug Metabolism Reviews|July 16, 2009
Drug interactionsAlan Boobis, Jean-Baptiste Watelet, Rhys Whomsley, et al.Drug Metabolism Reviews|May 19, 2010
Ozone applications to prevent and degrade mycotoxins: a reviewOtniel Freitas-Silva, Armando VenâncioDrug Metabolism Reviews|May 4, 2010
Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancerYan Li, Jezrael L Revalde, Glen Reid, et al.Drug Metabolism Reviews|September 29, 2009
Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediatorsKathleen M Knights, John O MinersDrug Metabolism Reviews|September 6, 2007
Comparative 1-substituted imidazole inhibition of cytochrome p450 isozyme-selective activities in human and mouse hepatic microsomesMichael R Franklin, Jonathan E ConstanceDrug Metabolism Reviews|September 6, 2007
Recalling P446. P4501A1 (CYP1A1) opting for clinical applicationAlfred G Hildebrandt, Dieter Schwarz, Solveigh Krusekopf, et al.Drug Metabolism Reviews|January 22, 2013
Nuclear receptors and endobiotics glucuronidation: the good, the bad, and the UGTCyril Bigo, Sarah Caron, Amélie Dallaire-Théroux, et al.Drug Metabolism Reviews|March 7, 2013
Substrate selectivity of human intestinal UDP-glucuronosyltransferases (UGTs): in silico and in vitro insightsSatya Prakash Tripathi, Anuseema Bhadauriya, Abhijeet Patil, et al.Pageof 85